Fly Study Reveals How the RNA Modifier Mettl16 Shapes Development and Fertility

In the bustling world of molecular biology, few chemical marks have attracted as much attention as N6-methyladenosine, commonly abbreviated m6A, the most abundant internal modification found on messenger RNA across eukaryotes. This tiny methyl group, added to the nitrogen at position six of adenosine bases, acts as a molecular post-it note that influences nearly every stage of an RNA molecule’s life, from how it is processed and exported out of the nucleus to how efficiently it is translated into protein and how quickly it is degraded. For years, researchers have concentrated on the enzyme complex built around METTL3, the dominant methyltransferase responsible for depositing the bulk of m6A marks. Yet a second enzyme, METTL16, has steadily emerged from the shadows, and a new study in fruit flies now reveals that this underappreciated writer of the epitranscriptome plays a strikingly specialized role in animal development, one that diverges in fascinating ways from what has been observed in mammals.

The research, led by Penghui Song, Lijuan Ma, and Dong Yan and published in PLOS Genetics, set out to answer a deceptively simple question: what does Mettl16 actually do in Drosophila melanogaster? In mammals, METTL16 is essential for embryonic development, and its loss is lethal, largely because it modifies a specific structural RNA involved in splicing and helps regulate the synthesis of S-adenosylmethionine, the universal methyl donor of the cell. Because flies lack some of the mammalian regulatory features, the expectation was that Mettl16 might behave similarly, or perhaps be dispensable altogether. The team generated flies carrying loss-of-function mutations in the Mettl16 gene and watched what happened across the entire life cycle. The result was unexpected: unlike in mammals, Mettl16 mutant flies survived to adulthood. They were alive, but far from well, displaying a constellation of developmental and behavioral abnormalities that hinted at a deep, if selective, importance of this enzyme.

The most dramatic phenotype was sterility. Both male and female mutants were completely infertile, and microscopic examination of their gonads revealed severe defects in gametogenesis, the intricate choreography by which germ cells divide, specialize, and mature into sperm and eggs. This was a crucial clue. Fertility is one of the most sensitive readouts of RNA metabolism, because germ cells undergo some of the most dramatic transcriptional and developmental transitions in any tissue. The fact that Mettl16 loss brought the entire reproductive program to a grinding halt suggested that the enzyme supports specific, non-redundant steps in the formation of gametes, rather than serving as a general housekeeping factor that cells could easily compensate for.

To pinpoint where things went wrong, the researchers traced germ cell development stage by stage. Remarkably, Mettl16 mutant germ cells were able to navigate the early milestones without obvious catastrophe: they completed the mitotic divisions that expand the germline population and progressed through meiosis, the specialized reductional division that generates haploid cells. The breakdown came later, during spermiogenesis, the transformation of round spermatids into the sleek, elongated, motile sperm that define male fertility. In the mutants, spermatid elongation faltered and individualization, the process by which each spermatid is sculpted, compacted, and encased in its own membrane sheath, failed to proceed properly. This stage-specific failure is telling, because spermatid elongation and individualization demand massive, precisely timed remodeling of the cytoskeleton, of chromatin, and of RNA populations inherited from earlier stages. Mettl16 therefore appears to be required for the late maturation program of sperm rather than for the fundamental mechanics of cell division.

Where does the enzyme live inside the cell, and what does it do when it gets there? The team tagged Mettl16 with green fluorescent protein and found that the fusion protein localized predominantly to the nucleus, consistent with a role in nuclear RNA processing rather than in the cytoplasmic control of translation. To test whether Mettl16 loss broadly crippled protein synthesis, the researchers examined wing disc epithelial cells, a classic Drosophila model tissue, and found that global protein production was not impaired in the absence of the enzyme. This observation carries real weight. If Mettl16 were a major regulator of mRNA translation, its removal should have left a visible signature on the protein output of the cell. Instead, the data pointed toward a narrower, more targeted function, in which only a specific set of RNA substrates depends on Mettl16 activity.

That selectivity was confirmed at the level of the transcriptome-wide methylome. Using MeRIP-Seq, a technique that immunoprecipitates methylated RNA fragments and maps them back to the genome, the researchers compared the m6A landscape of normal flies with that of Mettl16 mutants. The comparison produced a striking contrast. When Mettl3 is lost, the effect on m6A is broad, sweeping away the modification from a large fraction of transcripts across the transcriptome. Mettl16 loss, by comparison, altered m6A on only a small subset of RNAs. This result reframes the two enzymes as complementary writers with distinct substrate preferences: Mettl3 acts as the bulk methyltransferase decorating thousands of messages, while Mettl16 behaves as a specialist, placing marks on a curated list of targets whose identity appears central to the phenotypes observed in the mutant flies.

Among those targets, one stood out with particular clarity: U6 snRNA, the small nuclear RNA that forms the catalytic heart of the spliceosome, the molecular machine that removes intervening sequences from pre-messenger RNAs. The team demonstrated that Mettl16 physically interacts with U6 snRNA and is required for its m6A modification. This finding connects the fly enzyme to one of the most conserved functions described for METTL16 in other organisms, the methylation of U6, and it immediately suggested a mechanism by which the enzyme could exert widespread downstream effects. Splicing is the process that stitches together the coding segments of genes, and alternative splicing allows a single gene to produce multiple protein variants. If Mettl16 fails to methylate U6, the spliceosome’s precision could be subtly compromised, reshuffling the splicing patterns of many genes even though only a handful of transcripts lose their m6A marks directly.

That prediction held up. The researchers found that Mettl16 mutants display widespread alterations in alternative splicing, meaning that the way numerous pre-messenger RNAs are assembled into mature messages changes throughout the animal. This splicing dysregulation provides a plausible mechanistic bridge between the enzyme’s narrow biochemical footprint and its pleiotropic developmental consequences. Genes required for spermatid elongation, for oogenesis, and for normal behavior could each be mis-spliced in the mutant, producing protein isoforms that are truncated, unstable, or functionally altered. The picture that emerges is one of indirect amplification: a single, targeted RNA modification on a core splicing component ripples outward into broad changes in gene expression, which in turn manifest as the sterile, behaviorally abnormal flies observed in the study.

The evolutionary implications of the work are equally compelling. Comparing flies with mammals reveals a remarkable divergence in biological logic. In mammals, METTL16 is indispensable, its loss lethal during embryogenesis, whereas in flies the enzyme is dispensable for viability but essential for reproduction and normal development. This kind of comparative data helps researchers understand how the epitranscriptome has been rewired across hundreds of millions of years of evolution, with the same chemical modification and the same family of writer enzymes being deployed in different tissues and at different developmental checkpoints depending on the organism. It also cautions against assuming that findings from one model system translate directly to another, a lesson with practical consequences for biomedical research that relies on m6A biology as a therapeutic target.

For the growing community of scientists studying RNA modifications, the Drosophila study adds an important piece to the puzzle of how m6A writers divide their labor. Mettl3 emerges as the generalist, methylating a broad swath of the transcriptome, while Mettl16 operates as a specialist whose most clearly defined substrate is the U6 snRNA at the heart of the splicing machinery. The pleiotropic phenotypes of Mettl16 mutants, from failed spermatid individualization to behavioral defects, most likely stem from the combination of direct m6A deposition on specific target transcripts and the indirect consequences of U6-dependent splicing regulation. As epitranscriptomics moves from cataloging modifications toward understanding their causal roles in development and disease, this fly work demonstrates that even a small subset of methylated RNAs, when left unmodified, can be enough to derail some of the most elaborate programs an animal ever runs, including the construction of the next generation itself.

Subject of Research: The role of the m6A methyltransferase Mettl16 in Drosophila development, fertility, and RNA splicing regulation

Article Title: Role of the m 6 A methyltransferase Mettl16 in Drosophila development

Article References: Song, P., Ma, L., & Yan, D. (2026). Role of the m6A methyltransferase Mettl16 in Drosophila development. PLOS Genetics, 22(9), e1012317. https://doi.org/10.1371/journal.pgen.1012317

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012317

Keywords: m6A, Mettl16, Drosophila, epitranscriptomics, RNA methylation, U6 snRNA, alternative splicing, gametogenesis, spermatid individualization, PLOS Genetics, methyltransferase, developmental biology